|
|
|
|
|
|
|
||||
| Home Help Feedback Subscriptions Archive Search Table of Contents | ||||
Development, Vol 126, Issue 8 1665-1674, Copyright © 1999 by Company of Biologists
JOURNAL ARTICLES |
AG Borycki, J Li, F Jin, CP Emerson and JA Epstein
Department of Cell and Developmental Biology, Division of Cardiovascular Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA. epsteinj@mail.med.upenn.edu
In developing vertebrate embryos, Pax3 is expressed in the neural tube and in the paraxial mesoderm that gives rise to skeletal muscles. Pax3 mutants develop muscular and neural tube defects; furthermore, Pax3 is essential for the proper activation of the myogenic determination factor gene, MyoD, during early muscle development and PAX3 chromosomal translocations result in muscle tumors, providing evidence that Pax3 has diverse functions in myogenesis. To investigate the specific functions of Pax3 in development, we have examined cell survival and gene expression in presomitic mesoderm, somites and neural tube of developing wild-type and Pax3 mutant (Splotch) mouse embryos. Disruption of Pax3 expression by antisense oligonucleotides significantly impairs MyoD activation by signals from neural tube/notochord and surface ectoderm in cultured presomitic mesoderm (PSM), and is accompanied by a marked increase in programmed cell death. In Pax3 mutant (Splotch) embryos, MyoD is activated normally in the hypaxial somite, but MyoD-expressing cells are disorganized and apoptosis is prevalent in newly formed somites, but not in the neural tube or mature somites. In neural tube and somite regions where cell survival is maintained, the closely related Pax7 gene is upregulated, and its expression becomes expanded into the dorsal neural tube and somites, where Pax3 would normally be expressed. These results establish that Pax3 has complementary functions in MyoD activation and inhibition of apoptosis in the somitic mesoderm and in repression of Pax7 during neural tube and somite development.
This article has been cited by other articles:
|
|
 |
|
  M. W. Majesky Developmental Basis of Vascular Smooth Muscle Diversity Arterioscler. Thromb. Vasc. Biol., June 1, 2007; 27(6): 1248 - 1258. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Buchberger, D. Freitag, and H.-H. Arnold A homeo-paired domain-binding motif directs Myf5 expression in progenitor cells of limb muscle Development, March 15, 2007; 134(6): 1171 - 1180. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Bajard, F. Relaix, M. Lagha, D. Rocancourt, P. Daubas, and M. E. Buckingham A novel genetic hierarchy functions during hypaxial myogenesis: Pax3 directly activates Myf5 in muscle progenitor cells in the limb Genes & Dev., September 1, 2006; 20(17): 2450 - 2464. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X. Shi and D. J. Garry Muscle stem cells in development, regeneration, and disease. Genes & Dev., July 1, 2006; 20(13): 1692 - 1708. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Grifone, J. Demignon, C. Houbron, E. Souil, C. Niro, M. J. Seller, G. Hamard, and P. Maire Six1 and Six4 homeoproteins are required for Pax3 and Mrf expression during myogenesis in the mouse embryo Development, May 1, 2005; 132(9): 2235 - 2249. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Zou, D. Silvius, B. Fritzsch, and P.-X. Xu Eya1 and Six1 are essential for early steps of sensory neurogenesis in mammalian cranial placodes Development, November 15, 2004; 131(22): 5561 - 5572. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Keller, M. S. Hansen, C. M. Coffin, and M. R. Capecchi Pax3:Fkhr interferes with embryonic Pax3 and Pax7 function: implications for alveolar rhabdomyosarcoma cell of origin Genes & Dev., November 1, 2004; 18(21): 2608 - 2613. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Petropoulos, P. J. Gianakopoulos, A. G. Ridgeway, and I. S. Skerjanc Disruption of Meox or Gli Activity Ablates Skeletal Myogenesis in P19 Cells J. Biol. Chem., June 4, 2004; 279(23): 23874 - 23881. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Relaix, D. Rocancourt, A. Mansouri, and M. Buckingham Divergent functions of murine Pax3 and Pax7 in limb muscle development Genes & Dev., May 1, 2004; 18(9): 1088 - 1105. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Buttiglieri, M. C. Deregibus, S. Bravo, P. Cassoni, R. Chiarle, B. Bussolati, and G. Camussi Role of Pax2 in Apoptosis Resistance and Proinvasive Phenotype of Kaposi's Sarcoma Cells J. Biol. Chem., February 6, 2004; 279(6): 4136 - 4143. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Relaix, M. Polimeni, D. Rocancourt, C. Ponzetto, B. W. Schafer, and M. Buckingham The transcriptional activator PAX3-FKHR rescues the defects of Pax3 mutant mice but induces a myogenic gain-of-function phenotype with ligand-independent activation of Met signaling in vivo Genes & Dev., December 1, 2003; 17(23): 2950 - 2965. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Baumer, T. Marquardt, A. Stoykova, D. Spieler, D. Treichel, R. Ashery-Padan, and P. Gruss Retinal pigmented epithelium determination requires the redundant activities of Pax2 and Pax6 Development, July 1, 2003; 130(13): 2903 - 2915. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Laclef, G. Hamard, J. Demignon, E. Souil, C. Houbron, and P. Maire Altered myogenesis in Six1-deficient mice Development, May 15, 2003; 130(10): 2239 - 2252. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Pani, M. Horal, and M. R. Loeken Rescue of neural tube defects in Pax-3-deficient embryos by p53 loss of function: implications for Pax-3- dependent development and tumorigenesis Genes & Dev., March 15, 2002; 16(6): 676 - 680. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. C. Mootoosamy and S. Dietrich Distinct regulatory cascades for head and trunk myogenesis Development, January 2, 2002; 129(3): 573 - 583. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Matsunaga, I. Araki, and H. Nakamura Role of Pax3/7 in the tectum regionalization Development, October 15, 2001; 128(20): 4069 - 4077. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Anderson, A. Ramsay, S. Gould, and K. Pritchard-Jones PAX3-FKHR Induces Morphological Change and Enhances Cellular Proliferation and Invasion in Rhabdomyosarcoma Am. J. Pathol., September 1, 2001; 159(3): 1089 - 1096. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Feiner, A. L. Webber, C. B. Brown, M. M. Lu, L. Jia, P. Feinstein, P. Mombaerts, J. A. Epstein, and J. A. Raper Targeted disruption of semaphorin 3C leads to persistent truncus arteriosus and aortic arch interruption Development, August 15, 2001; 128(16): 3061 - 3070. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. B. Brown, L. Feiner, M.-M. Lu, J. Li, X. Ma, A. L. Webber, L. Jia, J. A. Raper, and J. A. Epstein PlexinA2 and semaphorin signaling during cardiac neural crest development Development, August 15, 2001; 128(16): 3071 - 3080. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. J. Hawke and D. J. Garry Myogenic satellite cells: physiology to molecular biology J Appl Physiol, August 1, 2001; 91(2): 534 - 551. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Ayyanathan, W. J. Fredericks, C. Berking, M. Herlyn, C. Balakrishnan, E. Gunther, and F. J. Rauscher III Hormone-dependent Tumor Regression in Vivo by an Inducible Transcriptional Repressor Directed at the PAX3-FKHR Oncogene Cancer Res., October 1, 2000; 60(20): 5803 - 5814. [Abstract] [Full Text]
|
|
|
|
 |
|
 S. J. Conway, J. Bundy, J. Chen, E. Dickman, R. Rogers, and B. M. Will Decreased neural crest stem cell expansion is responsible for the conotruncal heart defects within the Splotch (Sp2H)/Pax3 mouse mutant Cardiovasc Res, August 1, 2000; 47(2): 314 - 328. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. J. Fredericks, K. Ayyanathan, M. Herlyn, J. R. Friedman, and F. J. Rauscher III An Engineered PAX3-KRAB Transcriptional Repressor Inhibits the Malignant Phenotype of Alveolar Rhabdomyosarcoma Cells Harboring the Endogenous PAX3-FKHR Oncogene Mol. Cell. Biol., July 15, 2000; 20(14): 5019 - 5031. [Abstract] [Full Text]
|
|
|
|
|
|
A. Borycki, A. M. Brown, and C. P. Emerson Shh and Wnt signaling pathways converge to control Gli gene activation in avian somites Development, May 15, 2000; 127(10): 2075 - 2087. [Abstract] [PDF]
|
|
|
|
|
|
M Bouchard, P Pfeffer, and M Busslinger Functional equivalence of the transcription factors Pax2 and Pax5 in mouse development Development, January 9, 2000; 127(17): 3703 - 3713. [Abstract] [PDF]
|
|
|
|
|
|
J. Epstein, J Li, D Lang, F Chen, C. Brown, F Jin, M. Lu, M Thomas, E Liu, A Wessels, et al. Migration of cardiac neural crest cells in Splotch embryos Development, January 5, 2000; 127(9): 1869 - 1878. [Abstract] [PDF]
|
|
|
|
 |
|
 S. Porteous, E. Torban, N.-P. Cho, H. Cunliffe, L. Chua, L. McNoe, T. Ward, C. Souza, P. Gus, R. Giugliani, et al. Primary renal hypoplasia in humans and mice with PAX2 mutations: evidence of increased apoptosis in fetal kidneys of Pax21Neu +/- mutant mice Hum. Mol. Genet., January 1, 2000; 9(1): 1 - 11. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Relaix and M. Buckingham From insect eye to vertebrate muscle: redeployment of a regulatory network Genes & Dev., December 15, 1999; 13(24): 3171 - 3178. [Full Text]
|
|
|
|
|
|
T. A. Heanue, R. Reshef, R. J. Davis, G. Mardon, G. Oliver, S. Tomarev, A. B. Lassar, and C. J. Tabin Synergistic regulation of vertebrate muscle development by Dach2, Eya2, and Six1, homologs of genes required for Drosophila eye formation Genes & Dev., December 15, 1999; 13(24): 3231 - 3243. [Abstract] [Full Text]
|
|
|
|
|
|
H Peters, B Wilm, N Sakai, K Imai, R Maas, and R Balling Pax1 and Pax9 synergistically regulate vertebral column development Development, January 12, 1999; 126(23): 5399 - 5408. [Abstract] [PDF]
|
|
|
|
|
|
A. Borycki, B Brunk, S Tajbakhsh, M Buckingham, C Chiang, and C. Emerson Sonic hedgehog controls epaxial muscle determination through Myf5 activation Development, January 9, 1999; 126(18): 4053 - 4063. [Abstract] [PDF]
|
|
|
|
|
|
J Li, K. Liu, F Jin, M. Lu, and J. Epstein Transgenic rescue of congenital heart disease and spina bifida in Splotch mice Development, January 6, 1999; 126(11): 2495 - 2503. [Abstract] [PDF]
|
|
